Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 140


Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans.

Amor M, Itariu BK, Moreno-Viedma V, Keindl M, Jürets A, Prager G, Langer F, Grablowitz V, Zeyda M, Stulnig TM.

Exp Clin Endocrinol Diabetes. 2018 Aug 3. doi: 10.1055/a-0641-5546. [Epub ahead of print]


Cardiovascular Effects of Stress During Acutely Increased Free Fatty Acids in a Randomized, Double-Blind, Cross-Over Study in Humans.

Rezaei SS, Litschauer B, Gouya G, Baumgartner-Parzer S, Stulnig T, Wolzt M.

Horm Metab Res. 2018 Jun;50(6):478-484. doi: 10.1055/a-0620-8438. Epub 2018 Jun 8.


Loss of ABHD15 Impairs the Anti-lipolytic Action of Insulin by Altering PDE3B Stability and Contributes to Insulin Resistance.

Xia W, Pessentheiner AR, Hofer DC, Amor M, Schreiber R, Schoiswohl G, Eichmann TO, Walenta E, Itariu B, Prager G, Hackl H, Stulnig T, Kratky D, Rülicke T, Bogner-Strauss JG.

Cell Rep. 2018 May 15;23(7):1948-1961. doi: 10.1016/j.celrep.2018.04.055.


Corrigendum: Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness.

Morton NM, Beltram J, Carter RN, Michailidou Z, Gorjanc G, McFadden C, Barrios-Llerena ME, Rodriguez-Cuenca S, Gibbins MTG, Aird RE, Moreno-Navarrete JM, Munger SC, Svenson KL, Gastaldello A, Ramage L, Naredo G, Zeyda M, Wang ZV, Howie AF, Saari A, Sipilä P, Stulnig TM, Gudnason V, Kenyon CJ, Seckl JR, Walker BR, Webster SP, Dunbar DR, Churchill GA, Vidal-Puig A, Fernandez-Real JM, Emilsson V, Horvat S.

Nat Med. 2018 Apr 10;24(4):525. doi: 10.1038/nm0418-525e.


Pre- and peripartal management of a woman with McArdle disease: a case report.

Stopp T, Feichtinger M, Eppel W, Stulnig TM, Husslein P, Göbl C.

Gynecol Endocrinol. 2018 Mar 21:1-4. doi: 10.1080/09513590.2018.1451507. [Epub ahead of print]


Osteopontin-deficient progenitor cells display enhanced differentiation to adipocytes.

Moreno-Viedma V, Tardelli M, Zeyda M, Sibilia M, Burks JD, Stulnig TM.

Obes Res Clin Pract. 2018 May - Jun;12(3):277-285. doi: 10.1016/j.orcp.2018.02.006. Epub 2018 Mar 6.


Pompe disease in Austria: clinical, genetic and epidemiological aspects.

Löscher WN, Huemer M, Stulnig TM, Simschitz P, Iglseder S, Eggers C, Moser H, Möslinger D, Freilinger M, Lagler F, Grinzinger S, Reichhardt M, Bittner RE, Schmidt WM, Lex U, Brunner-Krainz M, Quasthoff S, Wanschitz JV.

J Neurol. 2018 Jan;265(1):159-164. doi: 10.1007/s00415-017-8686-6. Epub 2017 Nov 27.


AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M.

Tardelli M, Bruschi FV, Claudel T, Moreno-Viedma V, Halilbasic E, Marra F, Herac M, Stulnig TM, Trauner M.

Sci Rep. 2017 Nov 7;7(1):14661. doi: 10.1038/s41598-017-14557-9.


European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience.

van der Ploeg AT, Kruijshaar ME, Toscano A, Laforêt P, Angelini C, Lachmann RH, Pascual Pascual SI, Roberts M, Rösler K, Stulnig T, van Doorn PA, Van den Bergh PYK, Vissing J, Schoser B; European Pompe Consortium.

Eur J Neurol. 2017 Jun;24(6):768-e31. doi: 10.1111/ene.13285. Epub 2017 May 6. Review.


The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.

Bruschi FV, Claudel T, Tardelli M, Caligiuri A, Stulnig TM, Marra F, Trauner M.

Hepatology. 2017 Jun;65(6):1875-1890. doi: 10.1002/hep.29041. Epub 2017 Apr 18.


Upregulated TNF Expression 1 Year After Bariatric Surgery Reflects a Cachexia-Like State in Subcutaneous Adipose Tissue.

Jürets A, Itariu BK, Keindl M, Prager G, Langer F, Grablowitz V, Zeyda M, Stulnig TM.

Obes Surg. 2017 Jun;27(6):1514-1523. doi: 10.1007/s11695-016-2477-5.


Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity.

Tardelli M, Zeyda K, Moreno-Viedma V, Wanko B, Grün NG, Staffler G, Zeyda M, Stulnig TM.

Mol Metab. 2016 Sep 13;5(11):1131-1137. doi: 10.1016/j.molmet.2016.09.003. eCollection 2016 Nov.


Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.

Grün NG, Strohmeier K, Moreno-Viedma V, Le Bras M, Landlinger C, Zeyda K, Wanko B, Leitner L, Staffler G, Zeyda M, Stulnig TM.

Immunol Lett. 2016 Nov;179:85-94. doi: 10.1016/j.imlet.2016.09.006. Epub 2016 Sep 14.


Mast cells are not associated with systemic insulin resistance.

Einwallner E, Kiefer FW, Di Caro G, Orthofer M, Witzeneder N, Hörmann G, Itariu B, Zeyda M, Penninger JM, Stulnig TM, Esterbauer H, Todoric J.

Eur J Clin Invest. 2016 Nov;46(11):911-919. doi: 10.1111/eci.12675. Epub 2016 Oct 1.


Effects of Imiquimod on Hair Follicle Stem Cells and Hair Cycle Progression.

Amberg N, Holcmann M, Stulnig G, Sibilia M.

J Invest Dermatol. 2016 Nov;136(11):2140-2149. doi: 10.1016/j.jid.2016.06.613. Epub 2016 Jul 1.


Effects of Depilation Methods on Imiquimod-Induced Skin Inflammation in Mice.

Amberg N, Holcmann M, Stulnig G, Glitzner E, Sibilia M.

J Invest Dermatol. 2017 Feb;137(2):528-531. doi: 10.1016/j.jid.2016.09.018. Epub 2016 Sep 30. No abstract available.


Common dysregulated pathways in obese adipose tissue and atherosclerosis.

Moreno-Viedma V, Amor M, Sarabi A, Bilban M, Staffler G, Zeyda M, Stulnig TM.

Cardiovasc Diabetol. 2016 Aug 26;15(1):120. doi: 10.1186/s12933-016-0441-2.


Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.

Belmatoug N, Di Rocco M, Fraga C, Giraldo P, Hughes D, Lukina E, Maison-Blanche P, Merkel M, Niederau C, Plӧckinger U, Richter J, Stulnig TM, Vom Dahl S, Cox TM.

Eur J Intern Med. 2017 Jan;37:25-32. doi: 10.1016/j.ejim.2016.07.011. Epub 2016 Aug 10. Review.


A humanized osteopontin mouse model and its application in immunometabolic obesity studies.

Grün NG, Zeyda K, Moreno-Viedma V, Strohmeier K, Staffler G, Zeyda M, Stulnig TM.

Transl Res. 2016 Dec;178:63-73.e2. doi: 10.1016/j.trsl.2016.07.009. Epub 2016 Jul 18.


Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic disease.

Amor M, Moreno-Viedma V, Sarabi A, Grün NG, Itariu B, Leitner L, Steiner I, Bilban M, Kodama K, Butte AJ, Staffler G, Zeyda M, Stulnig TM.

Mol Med. 2016 Jun 30;22. doi: 10.2119/molmed.2016.00068. [Epub ahead of print]

Supplemental Content

Support Center